For instance, it has been reported that the prostate-specific membrane antigen (PSMA, also known as glutamate carboxypeptidase 2) level is much higher in prostatic cancer cells (100–1000-fold higher than normal prostate epithelial cells) [203]. The gene discussed is FOLH1; the disease is prostate carcinoma.